openPR Logo
Press release

Non-invasive Prenatal Testing (NIPT) Market | Forecast up to 2022

08-29-2017 12:25 AM CET | Health & Medicine

Press release from: Transparency Market Research - Medical Devices

Non-invasive Prenatal Testing (NIPT) Market | Forecast up

Global Non-invasive Prenatal Testing Market: Snapshot

Non-invasive prenatal testing (NIPT) has been garnering higher adoption especially in the cases of high risk pregnant women. Chromosomal disorders such as Edwards syndrome, down syndrome, Turner syndrome, and Patau syndrome are some of the diseases that can be screened using non-invasive prenatal testing. Gynecologists and pregnant women prefer the safety, non-invasiveness, and accuracy of non-invasive prenatal testing technology, although there are other testing techniques available such as amniocentesis and chorionic villus sampling. In October 2011, the premier non-invasive prenatal testing technology was launched by Sequenom, Inc., a U.S.- based a leading provider of extremely sensitive laboratory tests and innovator in the domain of molecular technology. The company held the leading position in the market by volume as well as revenue.

In 2013, the global non-invasive prenatal testing market was pegged that US$0.5 bn. The global NIPT market is expected to obtain a revenue worth US$2.38 bn by 2022, advancing rapidly at a phenomenal CAGR of 17.50% between 2014 and 2022.

View Report –
http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

High Prevalence of Chromosomal Disorders in Europe to Amp up Growth

By geography, Latin America, the Middle East and Africa, North America, Asia Pacific, and Europe can be the key segments of the global market for non-invasive prenatal testing. Of these, North America accounted for a volume of 51.0% and revenue of 58.8% in the global market for non-invasive prenatal testing market in 2013. The U.S. has been responsible for the growth of the segment due to the presence of several significant market players in the region. The findings of Down Syndrome Education (DSE), the frequency of Down Syndrome in the U.S. has been rising at a fast pace, leading to 4,700 cases on an annual basis, reflected in almost one in about 830 births in the U.S.

The prevalence of the condition is even higher in the European countries. It was found that one in every 920 newborns was diagnosed with Down syndrome. Because traditional testing methods such as chorionic villus sampling and amniocentesis can lead to miscarriage, the non-invasive prenatal testing technology is being increasingly recognized as a safe technique. The advancement of non-invasive prenatal tests enables an assessment of cell-free DANA that float in maternal plasma, thereby posing no risk of miscarriage.

The non-invasive prenatal testing market in Asia Pacific has been prognosticated to gain a large revenue in the global market, representing a vast chunk of the total market. The trend of late pregnancy has been leading to a growing incidence of complications among expecting mothers. This has been one of the basic propellants of the non-invasive prenatal testing market in the region. China, Australia, India and Japan are likely to surface as major contributors to the market's growth.

MaterniT20 PLUS Held Largest Share in Global Non-invasive Prenatal Testing Market in 2013

The global market for non-invasive prenatal testing can be segmented by the type of tests too. VisibiliT, informaSeq, MaterniT20 PLUS, NIFTY, BambniTest, verifi, Harmony, PrenaTest, and Panorama are some of the key segments of the global market for non-invasive prenatal testing. During 2013 the MaterniT20 PLUS segment held a share of 36.1% of the overall market for NIPT. However, over the oncoming period, the NIFTY, Panorama, Bambni, and Verifi are slated to advance at a greater pace, waiting in the wings to replace the MaterniT20 PLUS market segment.

Berry Genomics, Illumina, Inc., BGI Health, Sequenom, Inc., LabCorp, Ariosa Diagnostics, LifeCodexx AG, and Natera, Inc. are some leading companies operating in the global market for non-invasive prenatal testing market.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Non-invasive Prenatal Testing (NIPT) Market during 2014- 2022

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-invasive Prenatal Testing (NIPT) Market | Forecast up to 2022 here

News-ID: 687711 • Views:

More Releases from Transparency Market Research - Medical Devices

Dermatoscope Market - Global Industry Analysis 2024
Dermatoscope Market - Global Industry Analysis 2024
Dermatoscopy is a process through which the examination of skin lesions can be determined using an instrument, i.e., dermatoscope. The instrument is used by dermatologists to distinguish benign tumors and malignant (cancerous) lesions, especially in the diagnosis of melanoma. Modern dermatoscope uses the liquid medium and polarized light in order to cancel out the skin surface reflection. The images or videos are digitally processed using a digital epiluminescence dermatoscope. 3Gen
Medical Dynamometer Market - Global Industry Analysis and Forecast 2016 - 2024
Medical Dynamometer Market - Global Industry Analysis and Forecast 2016 - 2024
Dynamometer is a device used for measuring the torque and brake power which is required to operate a driven machine. Dynamometer is designed to be driven in the form of an absorption or passive dynamometer. The device can be in the form of pinch gauge, which is a handheld medical device used for measuring patients’ hand strength and trauma and for determining ongoing therapy and treatment process. It is utilized
Radiation Monitoring and Dosimeter Badges Market - Global Industry Analysis 2016 - 2024
Radiation Monitoring and Dosimeter Badges Market - Global Industry Analysis 2016 …
Radiation monitoring is a process that measures the radiation dose or number of radioactive particles reaching a particular surface or area. The radiation monitor device calculates the quantity of radiation present in a given space or received by an individual. The monitors are sensitive and possess properties such as speed counting, spatial resolution, and energy resolution. Radiation monitoring instruments or radiation monitors are used for both individual monitoring and area
Clinical Trial Imaging Market - Analysis and future growth opportunities by 2024
Clinical Trial Imaging Market - Analysis and future growth opportunities by 2024
Medical imaging plays a prominent role in clinical trials as it can help in providing answers to the critical challenges that occur in drug development process. It takes about 15 years for a drug to move from a laboratory set-up to FDA approval. The chances of a compound getting regulatory approval are minimal as out of 6 to 11,000 compounds that are evaluated in the pre-clinical stage, only 5 are

All 5 Releases


More Releases for NIPT

Non-Invasive Prenatal Testing Market has been analyzed from 2 viewpoints: NIPT T …
Worldwide Market Reports recently released “Global Non-Invasive Prenatal Testing Market Research Report 2017” that centers around the latest developing trends and technologies in the Non-Invasive Prenatal Testing Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022. During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives
United States Non-Invasive Prenatal Testing (NIPT) Market 2023
United States Non-Invasive Prenatal Testing (NIPT) Industry United States Non-Invasive Prenatal Testing (NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Latest Report on Non-Invasive Prenatal Testing (NIPT) Market United States Analysis & 2023 Forecast Research Study Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk
China $1.7 NIPT Test Market Outlook 2017-2024
China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024. Long–term Growth Projection and Development: • It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024 • More than 3,00,000 NIFTY tests done in 2016 • Berry Genomics completes US$ 648 Million reverse merger in Shenzhen • Two–Child policy is likely to boost China NIPT market Growth in China NIPT market can
2017 - 2021 : NIPT Test Market & Forecast
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Buy Now @: www.dpiresearch.com/report-details.php?P_ID=93 Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow
2017-2023 : US NIPT Test Market
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Buy Now @ http://www.dpiresearch.com/report-details.php?P_ID=100 Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of
Indian NIPT Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Indian NIPT Market Outlook 2022 to its growing collection of premium market research reports. NIPT helps obstetricians and pregnant women over different age-groups to better manage their pregnancy at a very early stage. Over the last few years, an increasing number of women in Tier-1 cities in India are giving preference to their career, and are opting for childbearing at a